文献速递肝病

以磁共振成像质子密度脂肪分数为金标准检测肝脂肪变时受控衰减参数的最佳阈值

Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
PubMed 文献 · Hepatology · 2018-02-19

这项前瞻性横断面研究纳入119名有无非酒精性脂肪性肝病的成人,在6个月内接受磁共振成像质子密度脂肪分数和受控衰减参数检测。受控衰减参数诊断磁共振成像质子密度脂肪分数≥5%的曲线下面积为0.80,切点288 dB/m;诊断≥10%的曲线下面积为0.87,切点306 dB/m。受控衰减参数四分位间距<30 dB/m时诊断准确性更可靠。

要点

  • 受控衰减参数诊断磁共振成像质子密度脂肪分数≥5%的切点为288 dB/m,曲线下面积0.80。
  • 受控衰减参数诊断磁共振成像质子密度脂肪分数≥10%的切点为306 dB/m,曲线下面积0.87。
  • 受控衰减参数四分位间距<30 dB/m时曲线下面积0.92,高于≥30 dB/m的0.70(P=0.0117)。

核心结论

  • 受控衰减参数诊断肝脂肪变(磁共振成像质子密度脂肪分数≥5%)的切点为288 dB/m。
  • 受控衰减参数四分位间距<30 dB/m时,其检测肝脂肪变的诊断准确性更可靠。

研究设计与样本

  • 前瞻性横断面研究,纳入119名有无非酒精性脂肪性肝病的成人(59%为女性)。
  • 受试者在加州大学圣地亚哥分校非酒精性脂肪性肝病研究中心6个月内接受磁共振成像质子密度脂肪分数和受控衰减参数检测,必要时使用M或XL探头。
  • 平均年龄52.4(±15.2)岁,平均体重指数29.9(±5.5)kg/m2。

主要发现

  • 非酒精性脂肪性肝病(磁共振成像质子密度脂肪分数≥5%)患病率为70.6%,磁共振成像质子密度脂肪分数≥10%的患病率为47.1%。
  • 受控衰减参数诊断磁共振成像质子密度脂肪分数≥5%的曲线下面积为0.80(95%CI 0.70-0.90),切点288 dB/m。
  • 受控衰减参数诊断磁共振成像质子密度脂肪分数≥10%的曲线下面积为0.87(95%CI 0.80-0.94),切点306 dB/m。
  • 受控衰减参数四分位间距低于中位数(30 dB/m)时曲线下面积为0.92(95%CI 0.85-1.00),高于中位数时为0.70(95%CI 0.56-0.85),差异有统计学和临床意义(P=0.0117)。

关键数值与推荐

  • 磁共振成像质子密度脂肪分数≥5%定义为存在肝脂肪变。
  • 受控衰减参数诊断磁共振成像质子密度脂肪分数≥5%的切点为288 dB/m。
  • 受控衰减参数诊断磁共振成像质子密度脂肪分数≥10%的切点为306 dB/m。
  • 受控衰减参数四分位间距<30 dB/m时诊断准确性更可靠。

临床怎么用

  • 这些数据对受控衰减参数在非酒精性脂肪性肝病评估中的临床使用有启示。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: The optimal threshold of controlled attenuation parameter (CAP) for the detection of hepatic steatosis using both M and XL probe is unknown in nonalcoholic fatty liver disease (NAFLD). Magnetic resonance imaging proton density fat fraction (MRI-PDFF) is an accurate and precise method of detecting the presence of hepatic steatosis that is superior to CAP. Thus, the aim of this study was to evaluate the diagnostic accuracy and optimal threshold of CAP for the detection of hepatic steatosis as defined by MRI-PDFF ≥ 5%. This prospective cross-sectional study included 119 adults (59% women) with and without NAFLD who underwent MRI-PDFF and CAP using either M or XL probe when indicated within a 6-month period at the NAFLD Research Center, University of California, San Diego. The mean ( ± standard deviation) age and body mass index were 52.4 (±15.2) years and 29.9 (±5.5) kg/m2 , respectively. The prevalence of NAFLD (MRI-PDFF ≥ 5%) and MRI-PDFF ≥ 10% was 70.6% and 47.1%, respectively. The area under the receiver operating characteristic (AUROC) of CAP for the detection of MRI-PDFF ≥ 5% was 0.80 (95% confidence interval [CI], 0.70-0.90) at the cut-point of 288 dB/m and of MRI-PDFF ≥ 10% was 0.87 (95% CI, 0.80-0.94) at the cut-point of 306 dB/m. When stratified by the interquartile range (IQR) of CAP, we observed that an IQR below the median (30 dB/m) had a robust AUROC compared with an IQR above the median (0.92 [95% CI, 0.85-1.00] versus 0.70 [95% CI, 0.56-0.85]; P = 0.0117), and these differences were statistically and clinically significant. CONCLUSION: The cut-point of CAP for presence of hepatic steatosis (MRI-PDFF ≥ 5%) was 288 dB/m. The diagnostic accuracy of CAP for the detection of hepatic steatosis is more reliable when the IQR of CAP is <30 dB/m. These data have implications for the clinical use of CAP in the assessment of NAFLD. (Hepatology 2018;67:1348-1359).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Caussy C, Alquiraish MH, Nguyen P, et al. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology. 2018. PMID: 29108123. doi:10.1002/hep.29639

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。